JW (Cayman) Therapeutics Co. Ltd

SEHK:2126 Stock Report

Market Cap: HK$534.0m

JW (Cayman) Therapeutics Dividends and Buybacks

Dividend criteria checks 0/6

JW (Cayman) Therapeutics does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-0.05%

Buyback Yield

Total Shareholder Yield-0.05%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Take Care Before Jumping Onto JW (Cayman) Therapeutics Co. Ltd (HKG:2126) Even Though It's 26% Cheaper

Nov 12
Take Care Before Jumping Onto JW (Cayman) Therapeutics Co. Ltd (HKG:2126) Even Though It's 26% Cheaper

JW (Cayman) Therapeutics Co. Ltd (HKG:2126) Screens Well But There Might Be A Catch

Sep 25
JW (Cayman) Therapeutics Co. Ltd (HKG:2126) Screens Well But There Might Be A Catch

A Piece Of The Puzzle Missing From JW (Cayman) Therapeutics Co. Ltd's (HKG:2126) 34% Share Price Climb

May 10
A Piece Of The Puzzle Missing From JW (Cayman) Therapeutics Co. Ltd's (HKG:2126) 34% Share Price Climb

Calculating The Intrinsic Value Of JW (Cayman) Therapeutics Co. Ltd (HKG:2126)

May 03
Calculating The Intrinsic Value Of JW (Cayman) Therapeutics Co. Ltd (HKG:2126)

JW (Cayman) Therapeutics Co. Ltd (HKG:2126): When Will It Breakeven?

Feb 03
JW (Cayman) Therapeutics Co. Ltd (HKG:2126): When Will It Breakeven?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if 2126's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 2126's dividend payments have been increasing.


Dividend Yield vs Market

JW (Cayman) Therapeutics Dividend Yield vs Market
How does 2126 dividend yield compare to the market?
SegmentDividend Yield
Company (2126)n/a
Market Bottom 25% (HK)3.3%
Market Top 25% (HK)8.1%
Industry Average (Biotechs)1.1%
Analyst forecast (2126) (up to 3 years)0%

Notable Dividend: Unable to evaluate 2126's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 2126's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate 2126's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 2126 has not reported any payouts.


Discover strong dividend paying companies